Feature Channels:

Immunology

Add to Favorites Subscribe Share
fbshare-Immunology

Showing results

110 of 1781

Article ID: 719135

Adding Radiation After Immunotherapy Improves Survival Time for Patients with Advanced Lung Cancer

Yale Cancer Center

The results of a phase II clinical trial by Yale Cancer Center (YCC) researchers show adding high-dose radiation after immunotherapy stops working increases survival time for patients with metastatic non-small-cell lung cancer (NSCLC).

Released:
17-Sep-2019 3:55 PM EDT
Newswise: Radiation May Lower Potential for Side Effects of CAR T Therapy in Non-Hodgkin’s Lymphoma
  • Embargo expired:
    17-Sep-2019 3:45 PM EDT

Article ID: 718718

Radiation May Lower Potential for Side Effects of CAR T Therapy in Non-Hodgkin’s Lymphoma

Perelman School of Medicine at the University of Pennsylvania

Treating non-Hodgkin’s lymphoma (NHL) patients with radiation therapy as an additional treatment while they wait for their CAR T cells to be manufactured may reduce the risk of CAR T therapy side effects once it is administered.

Released:
10-Sep-2019 9:00 AM EDT

Research Results

Channels:

Cancer, Cell Biology, Immunology, Medical Meetings

Languages:

English

Article ID: 719102

UTSW researchers identify new pathway that controls fat formation

UT Southwestern Medical Center

In work suggesting new therapeutic targets to fight obesity, UT Southwestern researchers have identified a novel mechanism that regulates the creation of fat in mammals.

Released:
17-Sep-2019 1:05 PM EDT
New Logo.png

Article ID: 719086

UChicago-led effort receives Grand Challenges Grant for research developing universal influenza vaccine

University of Chicago Medical Center

Patrick Wilson, PhD, professor of medicine and rheumatology at the University of Chicago, and a group of researchers from three other institutions have received aGrand Challenge for Universal Influenza Vaccine Development grant – a $12 million initiative funded by the Bill & Melinda Gates Foundation and Flu Lab.

Released:
17-Sep-2019 11:05 AM EDT

Announcement

Channels:

Immunology, Infectious Diseases, Public Health, Vaccines, Influenza

Languages:

English

Newswise: Racism a Factor in Asthma Control for Young African American Children
  • Embargo expired:
    17-Sep-2019 12:00 AM EDT

Article ID: 718889

Racism a Factor in Asthma Control for Young African American Children

American College of Allergy, Asthma and Immunology (ACAAI)

A new article in Annals of Allergy, Asthma and Immunology shows an association between African American parents/guardians who have experienced the chronic stress associated with exposure to racism and poor asthma control in their young children.

Released:
12-Sep-2019 10:05 AM EDT
Newswise: Cancer Protocols: A New Approach to Predicting Treatment Outcomes

Article ID: 718957

Cancer Protocols: A New Approach to Predicting Treatment Outcomes

Weizmann Institute of Science

Research by the Weizmann Institute of Science's Prof. Yardena Samuels shows that heterogeneity in melanoma tumors prevents effective immune responses

Released:
13-Sep-2019 1:45 PM EDT
PennMed_logo.png

Article ID: 718921

Penn Announces Completion of Exclusive R&D Alliance With Novartis and Development of New Focused Relationship

Perelman School of Medicine at the University of Pennsylvania

The University of Pennsylvania and Novartis have concluded their seven-year research and development alliance, which resulted in the world’s first approved gene therapy for cancer. They will continue to work together on a more narrow CAR T cell therapy clinical trials portfolio.

Released:
12-Sep-2019 2:05 PM EDT
Newswise: Texas Biomed Researchers Pinpoint Why HIV Patients Are More Likely to Develop Tuberculosis

Article ID: 718896

Texas Biomed Researchers Pinpoint Why HIV Patients Are More Likely to Develop Tuberculosis

Texas Biomedical Research Institute

Tuberculosis and HIV – two of the world’s deadliest infectious diseases – are far worse when they occur together. Now, Texas Biomedical Research Institute researchers have pinpointed an important mechanism at work in this troubling health problem. And, their discovery could lead to a new mode of treatment for people at risk.

Released:
12-Sep-2019 11:05 AM EDT
Newswise: Can scientists predict which cancer markers are likely to trigger an immune response?

Article ID: 718890

Can scientists predict which cancer markers are likely to trigger an immune response?

University of North Carolina Health Care System

In a study published in the journal Cancer Immunology Research, University of North Carolina Lineberger Comprehensive Cancer Center researchers reported on the discovery of a method for predicting whether abnormal proteins produced by cancer cells could trigger an immune response.

Released:
12-Sep-2019 11:05 AM EDT
APS_Profile.jpg
  • Embargo expired:
    11-Sep-2019 1:15 PM EDT

Article ID: 718372

Fighting Cancer with Math

American Physiological Society (APS)

Researchers gather today to discuss how mathematical models of the body’s smallest vessels can improve our understanding and treatment of cancer. They will present their findings at the American Physiological Society (APS) Interface of Mathematical Models and Experimental Biology conference.

Released:
5-Sep-2019 12:05 PM EDT

Showing results

110 of 1781

Chat now!